KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Goodwill Amortization of Goodwill Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Cvs Health (CVS) Deferred Taxes (2016 - 2024)

Cvs Health's Deferred Taxes history spans 16 years, with the latest figure at -$217.0 million for Q1 2024.

For the quarter ending Q1 2024, Deferred Taxes fell 240.0% year-over-year to -$217.0 million, compared with a TTM value of -$1.0 billion through Mar 2024, up 38.32%, and an annual FY2025 reading of $102.0 million, up 117.83% over the prior year.
Deferred Taxes for Q1 2024 was -$217.0 million at Cvs Health, up from -$316.0 million in the prior quarter.
The five-year high for Deferred Taxes was $243.0 million in Q4 2021, with the low at -$2.0 billion in Q3 2022.
Average Deferred Taxes over 5 years is -$229.1 million, with a median of -$166.0 million recorded in 2021.
Year-over-year, Deferred Taxes skyrocketed 1800.0% in 2020 and then plummeted 615.27% in 2022.
Tracing CVS's Deferred Taxes over 5 years: stood at -$545.0 million in 2020, then skyrocketed by 144.59% to $243.0 million in 2021, then fell by 24.28% to $184.0 million in 2022, then crashed by 271.74% to -$316.0 million in 2023, then soared by 31.33% to -$217.0 million in 2024.
Per Business Quant, the three most recent readings for CVS's Deferred Taxes are -$217.0 million (Q1 2024), -$316.0 million (Q4 2023), and -$447.0 million (Q3 2023).